Gaize

Gaize is an impairment detection technology that uses automated eye tests to identify current impairment from drugs including marijuana, alcohol, opiates, stimulants, and more. The system consists of a headset that captures high-precision ocular data and video evidence, analyzed by machine learning models to produce results in about 6 minutes. It is over 98% accurate and provides objective, defensible evidence of impairment. Gaize is designed for safety-sensitive workplaces and is 50-state legal in the US. It requires no body fluids and can reduce reliance on lab-based chemical testing, offering faster results at lower cost.

Key Features

• Broad spectrum detection: covers cannabis, alcohol, opioids, stimulants, dissociative anesthetics, and some psychedelics.
• Over 98% accuracy in clinical trials.
• Objective evidence with human-interpretable video.
• Fully automated, no expertise required.
• Results in real-time with downloadable reports.

Use Cases

• Workplace impairment screening for safety-sensitive industries.
• Post-incident testing and reasonable suspicion checks.
• Deterrent against on-the-job drug use.

Who It’s For

• Fortune 500s and small businesses.
• Safety directors and HR teams.
• Law enforcement agencies (separate product line).

Workflow

1. Capture: The headset automatically records eye movement, pupil size, head movement, and other factors.
2. Analyze: Data is processed by proprietary impairment detection models.
3. Report: Results are stored and accessible from anywhere, with clear reporting.

Key Benefits

• Over 98% accurate at detecting impairment indicators
• Provides objective evidence with video recording
• Detects impairment from a broad spectrum of drugs
• 50-state legal and defensible in court